Difference between revisions of "Test"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 67: | Line 67: | ||
- [[Myeloid Neoplasms with Germline GATA2 Mutation]] | - [[Myeloid Neoplasms with Germline GATA2 Mutation]] | ||
| + | == Myelodysplastic Syndromes (MDS) == | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] | ||
| + | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MSD with Isolated del(5q)]] | ||
| + | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] | ||
| + | *[[Refractory Cytopenia of Childhood]] | ||
| + | == Myeloproliferative Neoplasms (MPN) == | ||
| + | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | ||
| + | *[[Chronic Neutrophilic Leukemia (CNL)]] | ||
| + | *[[Polycythemia Vera (PV)]] | ||
| + | *[[Primary Myelofibrosis (PMF)]] | ||
| + | *[[Essential Thrombocythemia (ET)]] | ||
| + | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]] | ||
| + | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | ||
| − | + | == Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) == | |
| − | + | *[[Chronic Myelomonocytic Leukemia (CMML)]] | |
| − | + | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]] | |
| − | + | *[[Juvenile Myelomonocytic Leukemia (JMML)]] | |
| − | + | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] | |
| − | + | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<comments /> | <comments /> | ||
Revision as of 16:52, 20 February 2021
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- AML with Recurrent Genetic Abnormalities
- AML with Myelodysplasia-Related Changes
- sub division
- sub-sub-sub division
- sub division
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - Acute Promyelocytic Leukemia (APL) with PML-RARA - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 - AML with t(6;9)(p23;q34.1); DEK-NUP214 - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 - AML with BCR-ABL1 - AML with Mutated NPM1 - AML with Biallelic Mutations of CEBPA - AML with Mutated RUNX1
- AML with Minimal Differentiation - AML without Maturation - AML with Maturation - Acute Myelomonocytic Leukemia - Acute Monoblastic and Monocytic Leukemia - Pure Erythroid Leukemia - Acute Megakaryoblastic Leukemia (AMKL) - Acute Basophilic Leukemia - Acute Panmyelosis with Myelofibrosis
- Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome - Myeloid Leukemia Associated with Down Syndrome
- Acute Undifferentiated Leukemia - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)
- Acute Myeloid Leukaemia with Germline CEBPA Mutation - Myeloid Neoplasms with Germline DDX41 Mutation - Myeloid Neoplasms with Germline RUNX1 Mutation - Myeloid Neoplasms with Germline ANKRD26 Mutation - Myeloid Neoplasms with Germline ETV6 Mutation - Myeloid Neoplasms with Germline GATA2 Mutation
Myelodysplastic Syndromes (MDS)
- MDS with Single Lineage Dysplasia
- MDS with Ring Sideroblasts (MDS-RS)
- MDS with Ring Sideroblasts and Multilineage Dysplasia
- MDS with Multilineage Dysplasia
- MDS with Excess Blasts
- MSD with Isolated del(5q)
- MDS, Unclassifiable
- Refractory Cytopenia of Childhood
Myeloproliferative Neoplasms (MPN)
- Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
- Chronic Neutrophilic Leukemia (CNL)
- Polycythemia Vera (PV)
- Primary Myelofibrosis (PMF)
- Essential Thrombocythemia (ET)
- Chronic Eosinophilic Leukemia, Not Otherwise Specified
- Myeloproliferative Neoplasm (MPN), Unclassifiable
Enable comment auto-refresher
Dan
Permalink |
Dan